Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.

@article{Michaud1997SubstrateDO,
  title={Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.},
  author={Audrey Michaud and Tracy Ann Williams and M. T. Chauvet and Pierre Corvol},
  journal={Molecular pharmacology},
  year={1997},
  volume={51 6},
  pages={1070-6}
}
Angiotensin I-converting enzyme (ACE) is composed of two highly similar domains (referred to here as the N and C domains) that play a central role in blood pressure regulation; ACE inhibitors are widely used in the treatment of hypertension. However, the negative regulator of hematopoiesis, N-acetyl-seryl-aspartyl-lysyl-prolyl (AcSDKP), is a specific substrate of the N domain-active site; thus, in addition to the cardiovascular function of ACE, the enzyme may be involved in hematopoietic stem… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 26 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 39 references

Effets de l’enalapril sur le métabolisme de l’Ac-SDKP circulant et le taux des progéniteurs hématopoietiques circulants (abstract)

  • L. Comte, V. Lorgeot, A. Allégraud, Y. Le Meur, V. Praloran, J.-C. Aldigier
  • Arch. Mal Coeur
  • 1996
1 Excerpt

Theoretical and practical aspects of proteinase inhibition kinetics

  • Bieth, J.-G
  • Methods Enzymol
  • 1995
1 Excerpt

Similar Papers

Loading similar papers…